Only when this has been achieved, the nanocapsules – loaded with active ingredients – can go to the next stage in the process and undergo preclinical studies. The goal is to develop transport vehicles that can be injected into humans to treat numerous diseases. It is already possible to "deliver active ingredients in a protected way to specific cells or organs in order to be able to release them there in a targeted manner," according to Katharina Landfester.
Univ. Prof. Dr. med. Volker Mailänder, who conducts research at the Center for Translational Nanomedicine at the University Clinic Mainz, makes clear that close cooperation between chemists, biologists and physicians is necessary in order to ultimately be able to successfully apply nanocapsules in medicine.